Breaking News

Recro Acquires Alkermes Mfg. Site in GA

Specializes in DEA controlled substance and sustained release formulations

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Recro Pharma, Inc., a pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain, has acquired the 97,000 sq.-ft. Gainesville, GA manufacturing facility from Alkermes plc. The site, Recro Gainesville LLC, is a solid dose contract development and manufacturing site that specializes in DEA controlled substance manufacturing and packaging, as well as sustained release formulations.   Recro offers a range of pharmaceutical development and manufacturing...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters